nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—Guanabenz—hypertension	0.23	1	CrCtD
Guanfacine—Adrenergic alpha2-Agonists—Guanabenz—hypertension	0.156	0.569	CiPCiCtD
Guanfacine—Adrenergic alpha2-Agonists—Clonidine—hypertension	0.118	0.431	CiPCiCtD
Guanfacine—attention deficit hyperactivity disorder—Clonidine—hypertension	0.0953	1	CpDpCtD
Guanfacine—NISCH—hypertension	0.0772	0.598	CbGaD
Guanfacine—Diclofenac—Clonidine—hypertension	0.0738	1	CrCrCtD
Guanfacine—ADRA2B—hypertension	0.0361	0.279	CbGaD
Guanfacine—NISCH—Guanabenz—hypertension	0.0306	0.233	CbGbCtD
Guanfacine—ADRA2A—hypertension	0.0158	0.122	CbGaD
Guanfacine—NISCH—Clonidine—hypertension	0.0139	0.106	CbGbCtD
Guanfacine—ADRA2B—Guanabenz—hypertension	0.00667	0.0508	CbGbCtD
Guanfacine—ADRA2B—Fenoldopam—hypertension	0.00527	0.0402	CbGbCtD
Guanfacine—ADRA2A—Methyldopa—hypertension	0.00507	0.0386	CbGbCtD
Guanfacine—ADRA2A—Guanabenz—hypertension	0.00464	0.0353	CbGbCtD
Guanfacine—ADRA2B—Prazosin—hypertension	0.00399	0.0304	CbGbCtD
Guanfacine—ADRA2A—Fenoldopam—hypertension	0.00366	0.0279	CbGbCtD
Guanfacine—ADRA2B—Carvedilol—hypertension	0.00345	0.0263	CbGbCtD
Guanfacine—ADRA2A—Doxazosin—hypertension	0.00338	0.0258	CbGbCtD
Guanfacine—ADRA2B—Clonidine—hypertension	0.00303	0.0231	CbGbCtD
Guanfacine—ADRA2A—Prazosin—hypertension	0.00278	0.0212	CbGbCtD
Guanfacine—ADRA2A—Carvedilol—hypertension	0.0024	0.0183	CbGbCtD
Guanfacine—ADRA2A—Clonidine—hypertension	0.0021	0.016	CbGbCtD
Guanfacine—CYP2C9—Eprosartan—hypertension	0.00207	0.0158	CbGbCtD
Guanfacine—CYP2C19—Torasemide—hypertension	0.00203	0.0155	CbGbCtD
Guanfacine—CYP2C19—Metoprolol—hypertension	0.00189	0.0144	CbGbCtD
Guanfacine—CYP2C9—Torasemide—hypertension	0.00169	0.0129	CbGbCtD
Guanfacine—CYP2C9—Candesartan—hypertension	0.00157	0.0119	CbGbCtD
Guanfacine—CYP2C19—Doxazosin—hypertension	0.00148	0.0113	CbGbCtD
Guanfacine—CYP2C19—Diltiazem—hypertension	0.00143	0.0109	CbGbCtD
Guanfacine—CYP3A4—Guanethidine—hypertension	0.00141	0.0108	CbGbCtD
Guanfacine—CYP2C19—Telmisartan—hypertension	0.00134	0.0102	CbGbCtD
Guanfacine—CYP2C9—Diltiazem—hypertension	0.00119	0.00905	CbGbCtD
Guanfacine—CYP2C9—Valsartan—hypertension	0.00109	0.00828	CbGbCtD
Guanfacine—CYP2C19—Timolol—hypertension	0.00108	0.00825	CbGbCtD
Guanfacine—CYP3A4—Hydralazine—hypertension	0.00107	0.00817	CbGbCtD
Guanfacine—CYP2C19—Nicardipine—hypertension	0.00105	0.00799	CbGbCtD
Guanfacine—CYP2C9—Irbesartan—hypertension	0.000968	0.00738	CbGbCtD
Guanfacine—CYP2C19—Propranolol—hypertension	0.000965	0.00736	CbGbCtD
Guanfacine—CYP2C9—Amlodipine—hypertension	0.00095	0.00724	CbGbCtD
Guanfacine—CYP2C9—Felodipine—hypertension	0.000916	0.00698	CbGbCtD
Guanfacine—CYP2C9—Nifedipine—hypertension	0.000886	0.00675	CbGbCtD
Guanfacine—CYP2C9—Nicardipine—hypertension	0.000872	0.00665	CbGbCtD
Guanfacine—CYP2C9—Carvedilol—hypertension	0.000872	0.00665	CbGbCtD
Guanfacine—CYP2C19—Atorvastatin—hypertension	0.000821	0.00626	CbGbCtD
Guanfacine—CYP3A4—Isradipine—hypertension	0.000812	0.00619	CbGbCtD
Guanfacine—CYP2C19—Losartan—hypertension	0.000751	0.00572	CbGbCtD
Guanfacine—CYP3A4—Indapamide—hypertension	0.000715	0.00545	CbGbCtD
Guanfacine—CYP3A4—Nisoldipine—hypertension	0.000715	0.00545	CbGbCtD
Guanfacine—CYP3A4—Diltiazem—hypertension	0.000691	0.00526	CbGbCtD
Guanfacine—CYP3A4—Eplerenone—hypertension	0.000691	0.00526	CbGbCtD
Guanfacine—CYP2C9—Atorvastatin—hypertension	0.000682	0.0052	CbGbCtD
Guanfacine—CYP2C19—Verapamil—hypertension	0.000662	0.00505	CbGbCtD
Guanfacine—CYP2C9—Losartan—hypertension	0.000624	0.00476	CbGbCtD
Guanfacine—CYP3A4—Enalapril—hypertension	0.000616	0.00469	CbGbCtD
Guanfacine—CYP3A4—Irbesartan—hypertension	0.000563	0.00429	CbGbCtD
Guanfacine—Guanabenz—NISCH—hypertension	0.000555	0.483	CrCbGaD
Guanfacine—CYP3A4—Amlodipine—hypertension	0.000552	0.00421	CbGbCtD
Guanfacine—CYP2C9—Verapamil—hypertension	0.000551	0.0042	CbGbCtD
Guanfacine—CYP3A4—Felodipine—hypertension	0.000533	0.00406	CbGbCtD
Guanfacine—CYP3A4—Nifedipine—hypertension	0.000515	0.00393	CbGbCtD
Guanfacine—CYP3A4—Carvedilol—hypertension	0.000507	0.00386	CbGbCtD
Guanfacine—CYP3A4—Nicardipine—hypertension	0.000507	0.00386	CbGbCtD
Guanfacine—CYP3A4—Propranolol—hypertension	0.000467	0.00356	CbGbCtD
Guanfacine—CYP3A4—Clonidine—hypertension	0.000445	0.00339	CbGbCtD
Guanfacine—CYP3A4—Atorvastatin—hypertension	0.000397	0.00302	CbGbCtD
Guanfacine—CYP3A4—Losartan—hypertension	0.000363	0.00277	CbGbCtD
Guanfacine—CYP3A4—Verapamil—hypertension	0.00032	0.00244	CbGbCtD
Guanfacine—Guanabenz—ADRA2B—hypertension	0.000259	0.226	CrCbGaD
Guanfacine—CYP2C19—urine—hypertension	0.000217	0.107	CbGeAlD
Guanfacine—CYP2C9—urine—hypertension	0.000168	0.083	CbGeAlD
Guanfacine—NISCH—myocardium—hypertension	0.000164	0.081	CbGeAlD
Guanfacine—CYP3A4—urine—hypertension	0.000128	0.0633	CbGeAlD
Guanfacine—NISCH—nephron tubule—hypertension	0.00012	0.0594	CbGeAlD
Guanfacine—NISCH—adrenal cortex—hypertension	0.000118	0.0584	CbGeAlD
Guanfacine—NISCH—heart—hypertension	0.000115	0.0565	CbGeAlD
Guanfacine—NISCH—smooth muscle tissue—hypertension	0.000114	0.0561	CbGeAlD
Guanfacine—Guanabenz—ADRA2A—hypertension	0.000113	0.0989	CrCbGaD
Guanfacine—NISCH—decidua—hypertension	0.000111	0.055	CbGeAlD
Guanfacine—NISCH—cortex of kidney—hypertension	0.000103	0.0508	CbGeAlD
Guanfacine—NISCH—medulla oblongata—hypertension	9.24e-05	0.0456	CbGeAlD
Guanfacine—NISCH—adrenal gland—hypertension	8.55e-05	0.0422	CbGeAlD
Guanfacine—Diclofenac—ALOX5—hypertension	4.5e-05	0.0392	CrCbGaD
Guanfacine—CYP2C9—heart—hypertension	4.31e-05	0.0213	CbGeAlD
Guanfacine—Diclofenac—ABCC1—hypertension	4.21e-05	0.0367	CrCbGaD
Guanfacine—ADRA2A—heart—hypertension	4.18e-05	0.0206	CbGeAlD
Guanfacine—CYP2C9—cardiovascular system—hypertension	4.07e-05	0.0201	CbGeAlD
Guanfacine—ADRA2A—decidua—hypertension	4.06e-05	0.02	CbGeAlD
Guanfacine—Diclofenac—CYP2C18—hypertension	3.89e-05	0.0339	CrCbGaD
Guanfacine—ADRA2A—cortex of kidney—hypertension	3.76e-05	0.0185	CbGeAlD
Guanfacine—Diclofenac—CXCL8—hypertension	3.72e-05	0.0324	CrCbGaD
Guanfacine—CYP2C19—endocrine gland—hypertension	3.6e-05	0.0178	CbGeAlD
Guanfacine—ADRA2A—cardiac atrium—hypertension	3.57e-05	0.0176	CbGeAlD
Guanfacine—ADRA2A—medulla oblongata—hypertension	3.37e-05	0.0166	CbGeAlD
Guanfacine—ADRA2A—adrenal gland—hypertension	3.12e-05	0.0154	CbGeAlD
Guanfacine—CYP3A4—kidney—hypertension	3.03e-05	0.015	CbGeAlD
Guanfacine—CYP2C9—endocrine gland—hypertension	2.79e-05	0.0138	CbGeAlD
Guanfacine—ADRA2A—endocrine gland—hypertension	2.7e-05	0.0133	CbGeAlD
Guanfacine—ADRA2A—central nervous system—hypertension	2.44e-05	0.012	CbGeAlD
Guanfacine—CYP3A4—endocrine gland—hypertension	2.13e-05	0.0105	CbGeAlD
Guanfacine—CYP3A4—central nervous system—hypertension	1.92e-05	0.00946	CbGeAlD
Guanfacine—Diclofenac—PTGS1—hypertension	1.9e-05	0.0166	CrCbGaD
Guanfacine—Diclofenac—CYP1A1—hypertension	1.74e-05	0.0151	CrCbGaD
Guanfacine—Diclofenac—PTGS2—hypertension	1.09e-05	0.00946	CrCbGaD
Guanfacine—Diclofenac—ALB—hypertension	9.68e-06	0.00843	CrCbGaD
Guanfacine—Malaise—Lisinopril—hypertension	6.65e-06	0.000147	CcSEcCtD
Guanfacine—Nausea—Propranolol—hypertension	6.64e-06	0.000146	CcSEcCtD
Guanfacine—Oedema—Ramipril—hypertension	6.64e-06	0.000146	CcSEcCtD
Guanfacine—Headache—Doxazosin—hypertension	6.64e-06	0.000146	CcSEcCtD
Guanfacine—Vertigo—Lisinopril—hypertension	6.63e-06	0.000146	CcSEcCtD
Guanfacine—Dry mouth—Timolol—hypertension	6.62e-06	0.000146	CcSEcCtD
Guanfacine—Constipation—Losartan—hypertension	6.62e-06	0.000146	CcSEcCtD
Guanfacine—Syncope—Lisinopril—hypertension	6.61e-06	0.000146	CcSEcCtD
Guanfacine—Vomiting—Eplerenone—hypertension	6.61e-06	0.000146	CcSEcCtD
Guanfacine—Feeling abnormal—Furosemide—hypertension	6.61e-06	0.000146	CcSEcCtD
Guanfacine—Rash—Fosinopril—hypertension	6.6e-06	0.000145	CcSEcCtD
Guanfacine—Dermatitis—Fosinopril—hypertension	6.59e-06	0.000145	CcSEcCtD
Guanfacine—Vomiting—Nifedipine—hypertension	6.56e-06	0.000145	CcSEcCtD
Guanfacine—Gastrointestinal pain—Furosemide—hypertension	6.56e-06	0.000145	CcSEcCtD
Guanfacine—Rash—Eplerenone—hypertension	6.56e-06	0.000145	CcSEcCtD
Guanfacine—Headache—Fosinopril—hypertension	6.56e-06	0.000145	CcSEcCtD
Guanfacine—Hypersensitivity—Trandolapril—hypertension	6.56e-06	0.000145	CcSEcCtD
Guanfacine—Dermatitis—Eplerenone—hypertension	6.55e-06	0.000144	CcSEcCtD
Guanfacine—Diarrhoea—Valsartan—hypertension	6.55e-06	0.000144	CcSEcCtD
Guanfacine—Asthenia—Clonidine—hypertension	6.55e-06	0.000144	CcSEcCtD
Guanfacine—Feeling abnormal—Betaxolol—hypertension	6.55e-06	0.000144	CcSEcCtD
Guanfacine—Confusional state—Timolol—hypertension	6.54e-06	0.000144	CcSEcCtD
Guanfacine—Vomiting—Verapamil—hypertension	6.54e-06	0.000144	CcSEcCtD
Guanfacine—Shock—Ramipril—hypertension	6.53e-06	0.000144	CcSEcCtD
Guanfacine—Hypersensitivity—Enalapril—hypertension	6.53e-06	0.000144	CcSEcCtD
Guanfacine—Abdominal pain—Perindopril—hypertension	6.52e-06	0.000144	CcSEcCtD
Guanfacine—Palpitations—Lisinopril—hypertension	6.52e-06	0.000144	CcSEcCtD
Guanfacine—Diarrhoea—Olmesartan—hypertension	6.52e-06	0.000144	CcSEcCtD
Guanfacine—Headache—Eplerenone—hypertension	6.52e-06	0.000144	CcSEcCtD
Guanfacine—Rash—Nifedipine—hypertension	6.51e-06	0.000144	CcSEcCtD
Guanfacine—Dermatitis—Nifedipine—hypertension	6.5e-06	0.000143	CcSEcCtD
Guanfacine—Abdominal pain—Irbesartan—hypertension	6.5e-06	0.000143	CcSEcCtD
Guanfacine—Oedema—Timolol—hypertension	6.49e-06	0.000143	CcSEcCtD
Guanfacine—Loss of consciousness—Lisinopril—hypertension	6.48e-06	0.000143	CcSEcCtD
Guanfacine—Rash—Verapamil—hypertension	6.48e-06	0.000143	CcSEcCtD
Guanfacine—Tachycardia—Ramipril—hypertension	6.48e-06	0.000143	CcSEcCtD
Guanfacine—Dermatitis—Verapamil—hypertension	6.48e-06	0.000143	CcSEcCtD
Guanfacine—Headache—Nifedipine—hypertension	6.47e-06	0.000143	CcSEcCtD
Guanfacine—Pruritus—Clonidine—hypertension	6.45e-06	0.000142	CcSEcCtD
Guanfacine—Abdominal pain—Hydrochlorothiazide—hypertension	6.45e-06	0.000142	CcSEcCtD
Guanfacine—Headache—Verapamil—hypertension	6.44e-06	0.000142	CcSEcCtD
Guanfacine—Hypersensitivity—Telmisartan—hypertension	6.44e-06	0.000142	CcSEcCtD
Guanfacine—Nausea—Indapamide—hypertension	6.43e-06	0.000142	CcSEcCtD
Guanfacine—Nausea—Diltiazem—hypertension	6.43e-06	0.000142	CcSEcCtD
Guanfacine—Hyperhidrosis—Ramipril—hypertension	6.42e-06	0.000141	CcSEcCtD
Guanfacine—Asthenia—Trandolapril—hypertension	6.38e-06	0.000141	CcSEcCtD
Guanfacine—Shock—Timolol—hypertension	6.38e-06	0.000141	CcSEcCtD
Guanfacine—Feeling abnormal—Losartan—hypertension	6.38e-06	0.000141	CcSEcCtD
Guanfacine—Nausea—Carvedilol—hypertension	6.36e-06	0.00014	CcSEcCtD
Guanfacine—Asthenia—Enalapril—hypertension	6.36e-06	0.00014	CcSEcCtD
Guanfacine—Abdominal pain—Furosemide—hypertension	6.34e-06	0.00014	CcSEcCtD
Guanfacine—Gastrointestinal pain—Losartan—hypertension	6.33e-06	0.00014	CcSEcCtD
Guanfacine—Dizziness—Valsartan—hypertension	6.33e-06	0.00014	CcSEcCtD
Guanfacine—Dizziness—Olmesartan—hypertension	6.3e-06	0.000139	CcSEcCtD
Guanfacine—Pruritus—Trandolapril—hypertension	6.3e-06	0.000139	CcSEcCtD
Guanfacine—Nausea—Doxazosin—hypertension	6.29e-06	0.000139	CcSEcCtD
Guanfacine—Arthralgia—Lisinopril—hypertension	6.28e-06	0.000138	CcSEcCtD
Guanfacine—Myalgia—Lisinopril—hypertension	6.28e-06	0.000138	CcSEcCtD
Guanfacine—Chest pain—Lisinopril—hypertension	6.28e-06	0.000138	CcSEcCtD
Guanfacine—Hyperhidrosis—Timolol—hypertension	6.27e-06	0.000138	CcSEcCtD
Guanfacine—Asthenia—Telmisartan—hypertension	6.27e-06	0.000138	CcSEcCtD
Guanfacine—Pruritus—Enalapril—hypertension	6.27e-06	0.000138	CcSEcCtD
Guanfacine—Anxiety—Lisinopril—hypertension	6.26e-06	0.000138	CcSEcCtD
Guanfacine—Diarrhoea—Clonidine—hypertension	6.24e-06	0.000138	CcSEcCtD
Guanfacine—Nausea—Fosinopril—hypertension	6.22e-06	0.000137	CcSEcCtD
Guanfacine—Discomfort—Lisinopril—hypertension	6.2e-06	0.000137	CcSEcCtD
Guanfacine—Hypotension—Ramipril—hypertension	6.2e-06	0.000137	CcSEcCtD
Guanfacine—Pruritus—Telmisartan—hypertension	6.18e-06	0.000136	CcSEcCtD
Guanfacine—Nausea—Eplerenone—hypertension	6.18e-06	0.000136	CcSEcCtD
Guanfacine—Dry mouth—Lisinopril—hypertension	6.14e-06	0.000135	CcSEcCtD
Guanfacine—Nausea—Nifedipine—hypertension	6.13e-06	0.000135	CcSEcCtD
Guanfacine—Abdominal pain—Losartan—hypertension	6.12e-06	0.000135	CcSEcCtD
Guanfacine—Nausea—Verapamil—hypertension	6.11e-06	0.000135	CcSEcCtD
Guanfacine—Asthenia—Captopril—hypertension	6.1e-06	0.000134	CcSEcCtD
Guanfacine—Diarrhoea—Trandolapril—hypertension	6.09e-06	0.000134	CcSEcCtD
Guanfacine—Vomiting—Valsartan—hypertension	6.09e-06	0.000134	CcSEcCtD
Guanfacine—Confusional state—Lisinopril—hypertension	6.07e-06	0.000134	CcSEcCtD
Guanfacine—Diarrhoea—Enalapril—hypertension	6.06e-06	0.000134	CcSEcCtD
Guanfacine—Hypotension—Timolol—hypertension	6.06e-06	0.000134	CcSEcCtD
Guanfacine—Hypersensitivity—Irbesartan—hypertension	6.06e-06	0.000134	CcSEcCtD
Guanfacine—Vomiting—Olmesartan—hypertension	6.06e-06	0.000134	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Ramipril—hypertension	6.05e-06	0.000133	CcSEcCtD
Guanfacine—Rash—Valsartan—hypertension	6.03e-06	0.000133	CcSEcCtD
Guanfacine—Dizziness—Clonidine—hypertension	6.03e-06	0.000133	CcSEcCtD
Guanfacine—Dermatitis—Valsartan—hypertension	6.03e-06	0.000133	CcSEcCtD
Guanfacine—Oedema—Lisinopril—hypertension	6.02e-06	0.000133	CcSEcCtD
Guanfacine—Pruritus—Captopril—hypertension	6.01e-06	0.000133	CcSEcCtD
Guanfacine—Hypersensitivity—Hydrochlorothiazide—hypertension	6.01e-06	0.000133	CcSEcCtD
Guanfacine—Rash—Olmesartan—hypertension	6.01e-06	0.000132	CcSEcCtD
Guanfacine—Insomnia—Ramipril—hypertension	6e-06	0.000132	CcSEcCtD
Guanfacine—Dermatitis—Olmesartan—hypertension	6e-06	0.000132	CcSEcCtD
Guanfacine—Headache—Valsartan—hypertension	6e-06	0.000132	CcSEcCtD
Guanfacine—Diarrhoea—Telmisartan—hypertension	5.98e-06	0.000132	CcSEcCtD
Guanfacine—Headache—Olmesartan—hypertension	5.97e-06	0.000132	CcSEcCtD
Guanfacine—Paraesthesia—Ramipril—hypertension	5.96e-06	0.000131	CcSEcCtD
Guanfacine—Shock—Lisinopril—hypertension	5.92e-06	0.000131	CcSEcCtD
Guanfacine—Asthenia—Perindopril—hypertension	5.92e-06	0.000131	CcSEcCtD
Guanfacine—Dyspnoea—Ramipril—hypertension	5.92e-06	0.00013	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Timolol—hypertension	5.91e-06	0.00013	CcSEcCtD
Guanfacine—Hypersensitivity—Furosemide—hypertension	5.91e-06	0.00013	CcSEcCtD
Guanfacine—Asthenia—Irbesartan—hypertension	5.9e-06	0.00013	CcSEcCtD
Guanfacine—Somnolence—Ramipril—hypertension	5.9e-06	0.00013	CcSEcCtD
Guanfacine—Dizziness—Trandolapril—hypertension	5.88e-06	0.00013	CcSEcCtD
Guanfacine—Tachycardia—Lisinopril—hypertension	5.87e-06	0.00013	CcSEcCtD
Guanfacine—Insomnia—Timolol—hypertension	5.87e-06	0.000129	CcSEcCtD
Guanfacine—Dizziness—Enalapril—hypertension	5.86e-06	0.000129	CcSEcCtD
Guanfacine—Asthenia—Hydrochlorothiazide—hypertension	5.85e-06	0.000129	CcSEcCtD
Guanfacine—Hypersensitivity—Betaxolol—hypertension	5.85e-06	0.000129	CcSEcCtD
Guanfacine—Dyspepsia—Ramipril—hypertension	5.84e-06	0.000129	CcSEcCtD
Guanfacine—Pruritus—Perindopril—hypertension	5.84e-06	0.000129	CcSEcCtD
Guanfacine—Paraesthesia—Timolol—hypertension	5.83e-06	0.000128	CcSEcCtD
Guanfacine—Pruritus—Irbesartan—hypertension	5.82e-06	0.000128	CcSEcCtD
Guanfacine—Hyperhidrosis—Lisinopril—hypertension	5.82e-06	0.000128	CcSEcCtD
Guanfacine—Diarrhoea—Captopril—hypertension	5.82e-06	0.000128	CcSEcCtD
Guanfacine—Vomiting—Clonidine—hypertension	5.8e-06	0.000128	CcSEcCtD
Guanfacine—Dyspnoea—Timolol—hypertension	5.78e-06	0.000128	CcSEcCtD
Guanfacine—Dizziness—Telmisartan—hypertension	5.78e-06	0.000127	CcSEcCtD
Guanfacine—Pruritus—Hydrochlorothiazide—hypertension	5.77e-06	0.000127	CcSEcCtD
Guanfacine—Decreased appetite—Ramipril—hypertension	5.77e-06	0.000127	CcSEcCtD
Guanfacine—Somnolence—Timolol—hypertension	5.77e-06	0.000127	CcSEcCtD
Guanfacine—Asthenia—Furosemide—hypertension	5.76e-06	0.000127	CcSEcCtD
Guanfacine—Rash—Clonidine—hypertension	5.75e-06	0.000127	CcSEcCtD
Guanfacine—Dermatitis—Clonidine—hypertension	5.75e-06	0.000127	CcSEcCtD
Guanfacine—Fatigue—Ramipril—hypertension	5.72e-06	0.000126	CcSEcCtD
Guanfacine—Headache—Clonidine—hypertension	5.72e-06	0.000126	CcSEcCtD
Guanfacine—Dyspepsia—Timolol—hypertension	5.71e-06	0.000126	CcSEcCtD
Guanfacine—Hypersensitivity—Losartan—hypertension	5.7e-06	0.000126	CcSEcCtD
Guanfacine—Asthenia—Betaxolol—hypertension	5.7e-06	0.000126	CcSEcCtD
Guanfacine—Nausea—Valsartan—hypertension	5.68e-06	0.000125	CcSEcCtD
Guanfacine—Pruritus—Furosemide—hypertension	5.68e-06	0.000125	CcSEcCtD
Guanfacine—Constipation—Ramipril—hypertension	5.68e-06	0.000125	CcSEcCtD
Guanfacine—Nausea—Olmesartan—hypertension	5.66e-06	0.000125	CcSEcCtD
Guanfacine—Vomiting—Trandolapril—hypertension	5.66e-06	0.000125	CcSEcCtD
Guanfacine—Diarrhoea—Perindopril—hypertension	5.65e-06	0.000125	CcSEcCtD
Guanfacine—Decreased appetite—Timolol—hypertension	5.64e-06	0.000124	CcSEcCtD
Guanfacine—Vomiting—Enalapril—hypertension	5.63e-06	0.000124	CcSEcCtD
Guanfacine—Diarrhoea—Irbesartan—hypertension	5.63e-06	0.000124	CcSEcCtD
Guanfacine—Hypotension—Lisinopril—hypertension	5.62e-06	0.000124	CcSEcCtD
Guanfacine—Dizziness—Captopril—hypertension	5.62e-06	0.000124	CcSEcCtD
Guanfacine—Pruritus—Betaxolol—hypertension	5.62e-06	0.000124	CcSEcCtD
Guanfacine—Rash—Trandolapril—hypertension	5.61e-06	0.000124	CcSEcCtD
Guanfacine—Dermatitis—Trandolapril—hypertension	5.6e-06	0.000124	CcSEcCtD
Guanfacine—Fatigue—Timolol—hypertension	5.59e-06	0.000123	CcSEcCtD
Guanfacine—Rash—Enalapril—hypertension	5.59e-06	0.000123	CcSEcCtD
Guanfacine—Dermatitis—Enalapril—hypertension	5.58e-06	0.000123	CcSEcCtD
Guanfacine—Diarrhoea—Hydrochlorothiazide—hypertension	5.58e-06	0.000123	CcSEcCtD
Guanfacine—Headache—Trandolapril—hypertension	5.57e-06	0.000123	CcSEcCtD
Guanfacine—Vomiting—Telmisartan—hypertension	5.56e-06	0.000123	CcSEcCtD
Guanfacine—Asthenia—Losartan—hypertension	5.55e-06	0.000122	CcSEcCtD
Guanfacine—Headache—Enalapril—hypertension	5.55e-06	0.000122	CcSEcCtD
Guanfacine—Rash—Telmisartan—hypertension	5.51e-06	0.000122	CcSEcCtD
Guanfacine—Dermatitis—Telmisartan—hypertension	5.51e-06	0.000121	CcSEcCtD
Guanfacine—Diarrhoea—Furosemide—hypertension	5.49e-06	0.000121	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Lisinopril—hypertension	5.48e-06	0.000121	CcSEcCtD
Guanfacine—Pruritus—Losartan—hypertension	5.48e-06	0.000121	CcSEcCtD
Guanfacine—Headache—Telmisartan—hypertension	5.48e-06	0.000121	CcSEcCtD
Guanfacine—Feeling abnormal—Ramipril—hypertension	5.47e-06	0.000121	CcSEcCtD
Guanfacine—Dizziness—Perindopril—hypertension	5.46e-06	0.00012	CcSEcCtD
Guanfacine—Insomnia—Lisinopril—hypertension	5.44e-06	0.00012	CcSEcCtD
Guanfacine—Dizziness—Irbesartan—hypertension	5.44e-06	0.00012	CcSEcCtD
Guanfacine—Diarrhoea—Betaxolol—hypertension	5.43e-06	0.00012	CcSEcCtD
Guanfacine—Gastrointestinal pain—Ramipril—hypertension	5.43e-06	0.00012	CcSEcCtD
Guanfacine—Nausea—Clonidine—hypertension	5.42e-06	0.000119	CcSEcCtD
Guanfacine—Paraesthesia—Lisinopril—hypertension	5.41e-06	0.000119	CcSEcCtD
Guanfacine—Vomiting—Captopril—hypertension	5.4e-06	0.000119	CcSEcCtD
Guanfacine—Dizziness—Hydrochlorothiazide—hypertension	5.39e-06	0.000119	CcSEcCtD
Guanfacine—Dyspnoea—Lisinopril—hypertension	5.37e-06	0.000118	CcSEcCtD
Guanfacine—Rash—Captopril—hypertension	5.36e-06	0.000118	CcSEcCtD
Guanfacine—Dermatitis—Captopril—hypertension	5.35e-06	0.000118	CcSEcCtD
Guanfacine—Somnolence—Lisinopril—hypertension	5.35e-06	0.000118	CcSEcCtD
Guanfacine—Feeling abnormal—Timolol—hypertension	5.35e-06	0.000118	CcSEcCtD
Guanfacine—Headache—Captopril—hypertension	5.32e-06	0.000117	CcSEcCtD
Guanfacine—Gastrointestinal pain—Timolol—hypertension	5.31e-06	0.000117	CcSEcCtD
Guanfacine—Dizziness—Furosemide—hypertension	5.31e-06	0.000117	CcSEcCtD
Guanfacine—Dyspepsia—Lisinopril—hypertension	5.3e-06	0.000117	CcSEcCtD
Guanfacine—Diarrhoea—Losartan—hypertension	5.3e-06	0.000117	CcSEcCtD
Guanfacine—Nausea—Trandolapril—hypertension	5.29e-06	0.000117	CcSEcCtD
Guanfacine—Nausea—Enalapril—hypertension	5.26e-06	0.000116	CcSEcCtD
Guanfacine—Dizziness—Betaxolol—hypertension	5.25e-06	0.000116	CcSEcCtD
Guanfacine—Vomiting—Perindopril—hypertension	5.25e-06	0.000116	CcSEcCtD
Guanfacine—Abdominal pain—Ramipril—hypertension	5.25e-06	0.000116	CcSEcCtD
Guanfacine—Decreased appetite—Lisinopril—hypertension	5.23e-06	0.000115	CcSEcCtD
Guanfacine—Vomiting—Irbesartan—hypertension	5.23e-06	0.000115	CcSEcCtD
Guanfacine—Rash—Perindopril—hypertension	5.2e-06	0.000115	CcSEcCtD
Guanfacine—Dermatitis—Perindopril—hypertension	5.2e-06	0.000115	CcSEcCtD
Guanfacine—Nausea—Telmisartan—hypertension	5.19e-06	0.000114	CcSEcCtD
Guanfacine—Fatigue—Lisinopril—hypertension	5.19e-06	0.000114	CcSEcCtD
Guanfacine—Vomiting—Hydrochlorothiazide—hypertension	5.19e-06	0.000114	CcSEcCtD
Guanfacine—Rash—Irbesartan—hypertension	5.19e-06	0.000114	CcSEcCtD
Guanfacine—Dermatitis—Irbesartan—hypertension	5.18e-06	0.000114	CcSEcCtD
Guanfacine—Headache—Perindopril—hypertension	5.17e-06	0.000114	CcSEcCtD
Guanfacine—Headache—Irbesartan—hypertension	5.15e-06	0.000114	CcSEcCtD
Guanfacine—Constipation—Lisinopril—hypertension	5.15e-06	0.000114	CcSEcCtD
Guanfacine—Rash—Hydrochlorothiazide—hypertension	5.14e-06	0.000113	CcSEcCtD
Guanfacine—Dermatitis—Hydrochlorothiazide—hypertension	5.14e-06	0.000113	CcSEcCtD
Guanfacine—Abdominal pain—Timolol—hypertension	5.13e-06	0.000113	CcSEcCtD
Guanfacine—Dizziness—Losartan—hypertension	5.12e-06	0.000113	CcSEcCtD
Guanfacine—Headache—Hydrochlorothiazide—hypertension	5.11e-06	0.000113	CcSEcCtD
Guanfacine—Vomiting—Furosemide—hypertension	5.1e-06	0.000112	CcSEcCtD
Guanfacine—Rash—Furosemide—hypertension	5.06e-06	0.000112	CcSEcCtD
Guanfacine—Dermatitis—Furosemide—hypertension	5.05e-06	0.000111	CcSEcCtD
Guanfacine—Vomiting—Betaxolol—hypertension	5.05e-06	0.000111	CcSEcCtD
Guanfacine—Nausea—Captopril—hypertension	5.05e-06	0.000111	CcSEcCtD
Guanfacine—Headache—Furosemide—hypertension	5.03e-06	0.000111	CcSEcCtD
Guanfacine—Rash—Betaxolol—hypertension	5.01e-06	0.00011	CcSEcCtD
Guanfacine—Dermatitis—Betaxolol—hypertension	5e-06	0.00011	CcSEcCtD
Guanfacine—Headache—Betaxolol—hypertension	4.98e-06	0.00011	CcSEcCtD
Guanfacine—Feeling abnormal—Lisinopril—hypertension	4.96e-06	0.000109	CcSEcCtD
Guanfacine—Gastrointestinal pain—Lisinopril—hypertension	4.92e-06	0.000109	CcSEcCtD
Guanfacine—Vomiting—Losartan—hypertension	4.92e-06	0.000109	CcSEcCtD
Guanfacine—Nausea—Perindopril—hypertension	4.9e-06	0.000108	CcSEcCtD
Guanfacine—Hypersensitivity—Ramipril—hypertension	4.89e-06	0.000108	CcSEcCtD
Guanfacine—Nausea—Irbesartan—hypertension	4.89e-06	0.000108	CcSEcCtD
Guanfacine—Rash—Losartan—hypertension	4.88e-06	0.000108	CcSEcCtD
Guanfacine—Dermatitis—Losartan—hypertension	4.88e-06	0.000108	CcSEcCtD
Guanfacine—Headache—Losartan—hypertension	4.85e-06	0.000107	CcSEcCtD
Guanfacine—Nausea—Hydrochlorothiazide—hypertension	4.85e-06	0.000107	CcSEcCtD
Guanfacine—Hypersensitivity—Timolol—hypertension	4.78e-06	0.000105	CcSEcCtD
Guanfacine—Nausea—Furosemide—hypertension	4.77e-06	0.000105	CcSEcCtD
Guanfacine—Asthenia—Ramipril—hypertension	4.76e-06	0.000105	CcSEcCtD
Guanfacine—Abdominal pain—Lisinopril—hypertension	4.76e-06	0.000105	CcSEcCtD
Guanfacine—Nausea—Betaxolol—hypertension	4.72e-06	0.000104	CcSEcCtD
Guanfacine—Pruritus—Ramipril—hypertension	4.7e-06	0.000104	CcSEcCtD
Guanfacine—Asthenia—Timolol—hypertension	4.66e-06	0.000103	CcSEcCtD
Guanfacine—Nausea—Losartan—hypertension	4.6e-06	0.000101	CcSEcCtD
Guanfacine—Pruritus—Timolol—hypertension	4.59e-06	0.000101	CcSEcCtD
Guanfacine—Diarrhoea—Ramipril—hypertension	4.54e-06	0.0001	CcSEcCtD
Guanfacine—Diarrhoea—Timolol—hypertension	4.44e-06	9.79e-05	CcSEcCtD
Guanfacine—Hypersensitivity—Lisinopril—hypertension	4.43e-06	9.78e-05	CcSEcCtD
Guanfacine—Dizziness—Ramipril—hypertension	4.39e-06	9.68e-05	CcSEcCtD
Guanfacine—Asthenia—Lisinopril—hypertension	4.32e-06	9.52e-05	CcSEcCtD
Guanfacine—Dizziness—Timolol—hypertension	4.29e-06	9.46e-05	CcSEcCtD
Guanfacine—Pruritus—Lisinopril—hypertension	4.26e-06	9.39e-05	CcSEcCtD
Guanfacine—Vomiting—Ramipril—hypertension	4.22e-06	9.31e-05	CcSEcCtD
Guanfacine—Rash—Ramipril—hypertension	4.18e-06	9.23e-05	CcSEcCtD
Guanfacine—Dermatitis—Ramipril—hypertension	4.18e-06	9.22e-05	CcSEcCtD
Guanfacine—Headache—Ramipril—hypertension	4.16e-06	9.17e-05	CcSEcCtD
Guanfacine—Vomiting—Timolol—hypertension	4.13e-06	9.1e-05	CcSEcCtD
Guanfacine—Diarrhoea—Lisinopril—hypertension	4.12e-06	9.08e-05	CcSEcCtD
Guanfacine—Rash—Timolol—hypertension	4.09e-06	9.02e-05	CcSEcCtD
Guanfacine—Dermatitis—Timolol—hypertension	4.09e-06	9.01e-05	CcSEcCtD
Guanfacine—Headache—Timolol—hypertension	4.06e-06	8.96e-05	CcSEcCtD
Guanfacine—Dizziness—Lisinopril—hypertension	3.98e-06	8.78e-05	CcSEcCtD
Guanfacine—Nausea—Ramipril—hypertension	3.94e-06	8.69e-05	CcSEcCtD
Guanfacine—Nausea—Timolol—hypertension	3.85e-06	8.5e-05	CcSEcCtD
Guanfacine—Vomiting—Lisinopril—hypertension	3.83e-06	8.44e-05	CcSEcCtD
Guanfacine—Rash—Lisinopril—hypertension	3.8e-06	8.37e-05	CcSEcCtD
Guanfacine—Dermatitis—Lisinopril—hypertension	3.79e-06	8.36e-05	CcSEcCtD
Guanfacine—Headache—Lisinopril—hypertension	3.77e-06	8.32e-05	CcSEcCtD
Guanfacine—Nausea—Lisinopril—hypertension	3.58e-06	7.88e-05	CcSEcCtD
Guanfacine—ADRA2A—Signaling Pathways—APOB—hypertension	8.07e-07	4.51e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GOT1—hypertension	8.05e-07	4.51e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTK2—hypertension	8.03e-07	4.5e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FN1—hypertension	8.02e-07	4.49e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PRKCB—hypertension	8.02e-07	4.49e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—F2—hypertension	8.02e-07	4.49e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CXCL8—hypertension	8e-07	4.48e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EDN1—hypertension	7.94e-07	4.44e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AGT—hypertension	7.88e-07	4.41e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL5—hypertension	7.88e-07	4.41e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOTCH1—hypertension	7.85e-07	4.39e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—STK11—hypertension	7.82e-07	4.38e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP19A1—hypertension	7.82e-07	4.38e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—TH—hypertension	7.8e-07	4.36e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CALM2—hypertension	7.77e-07	4.35e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—TP53—hypertension	7.77e-07	4.35e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LRP2—hypertension	7.76e-07	4.34e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP2C18—hypertension	7.76e-07	4.34e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CALM1—hypertension	7.75e-07	4.34e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOE—hypertension	7.72e-07	4.32e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LPL—hypertension	7.7e-07	4.31e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—hypertension	7.67e-07	4.29e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CAV1—hypertension	7.65e-07	4.28e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—H2AFX—hypertension	7.65e-07	4.28e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RPS6KB1—hypertension	7.63e-07	4.27e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PDGFRB—hypertension	7.63e-07	4.27e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOA1—hypertension	7.63e-07	4.27e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GCG—hypertension	7.58e-07	4.24e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SLC2A4—hypertension	7.58e-07	4.24e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ADCY5—hypertension	7.54e-07	4.22e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRKCG—hypertension	7.49e-07	4.19e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HSPG2—hypertension	7.47e-07	4.18e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ITGB3—hypertension	7.44e-07	4.16e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRKCA—hypertension	7.44e-07	4.16e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—YWHAZ—hypertension	7.38e-07	4.13e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GOT1—hypertension	7.34e-07	4.11e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hypertension	7.34e-07	4.11e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—POMC—hypertension	7.31e-07	4.09e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NGF—hypertension	7.29e-07	4.08e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SPP1—hypertension	7.29e-07	4.08e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—INS—hypertension	7.27e-07	4.07e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—COMT—hypertension	7.27e-07	4.07e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CXCL8—hypertension	7.26e-07	4.06e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALOX5—hypertension	7.21e-07	4.04e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GLP1R—hypertension	7.21e-07	4.04e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GNB3—hypertension	7.17e-07	4.01e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARGC1A—hypertension	7.17e-07	4.01e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCL2—hypertension	7.15e-07	4e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HMOX1—hypertension	7.14e-07	3.99e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—STK11—hypertension	7.13e-07	3.99e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP19A1—hypertension	7.13e-07	3.99e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCR5—hypertension	7.1e-07	3.97e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRKCD—hypertension	7.1e-07	3.97e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CAT—hypertension	7.04e-07	3.94e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IGF1—hypertension	7.03e-07	3.94e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT2—hypertension	7.03e-07	3.93e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hypertension	7e-07	3.92e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—EGFR—hypertension	7e-07	3.92e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GNAS—hypertension	6.98e-07	3.91e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HTR2A—hypertension	6.94e-07	3.89e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—C3—hypertension	6.93e-07	3.88e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOB—hypertension	6.83e-07	3.83e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PDGFB—hypertension	6.75e-07	3.78e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPARG—hypertension	6.73e-07	3.76e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGFR1—hypertension	6.71e-07	3.76e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hypertension	6.69e-07	3.75e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SERPINE1—hypertension	6.68e-07	3.74e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTM1—hypertension	6.65e-07	3.72e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—POMC—hypertension	6.63e-07	3.71e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—COMT—hypertension	6.63e-07	3.71e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HIF1A—hypertension	6.61e-07	3.7e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALDH2—hypertension	6.6e-07	3.69e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—INS—hypertension	6.6e-07	3.69e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AGT—hypertension	6.59e-07	3.69e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—AKT1—hypertension	6.56e-07	3.67e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARGC1A—hypertension	6.54e-07	3.66e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GNB3—hypertension	6.54e-07	3.66e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—LPL—hypertension	6.53e-07	3.65e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HMOX1—hypertension	6.51e-07	3.64e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CALM1—hypertension	6.48e-07	3.63e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FGF2—hypertension	6.46e-07	3.62e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LEP—hypertension	6.46e-07	3.61e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOE—hypertension	6.46e-07	3.61e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RHOA—hypertension	6.44e-07	3.6e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HBA1—hypertension	6.43e-07	3.6e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CAT—hypertension	6.42e-07	3.59e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CAV1—hypertension	6.4e-07	3.58e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP11A1—hypertension	6.39e-07	3.58e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ADCY5—hypertension	6.39e-07	3.58e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hypertension	6.38e-07	3.57e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOA1—hypertension	6.38e-07	3.57e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOS3—hypertension	6.37e-07	3.57e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3R1—hypertension	6.37e-07	3.57e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GPX1—hypertension	6.37e-07	3.56e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GNAS—hypertension	6.36e-07	3.56e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KDR—hypertension	6.32e-07	3.54e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP1A1—hypertension	6.3e-07	3.53e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PRKCA—hypertension	6.3e-07	3.53e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTT1—hypertension	6.28e-07	3.51e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC9A1—hypertension	6.28e-07	3.51e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOB—hypertension	6.23e-07	3.49e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GCLC—hypertension	6.2e-07	3.47e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CETP—hypertension	6.2e-07	3.47e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CD36—hypertension	6.2e-07	3.47e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—F2—hypertension	6.09e-07	3.41e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRKCB—hypertension	6.09e-07	3.41e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FN1—hypertension	6.09e-07	3.41e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTM1—hypertension	6.06e-07	3.39e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ALB—hypertension	6.05e-07	3.38e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RELA—hypertension	6e-07	3.36e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOTCH1—hypertension	5.96e-07	3.33e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—LPL—hypertension	5.95e-07	3.33e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP17A1—hypertension	5.94e-07	3.33e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MTOR—hypertension	5.88e-07	3.29e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ENO1—hypertension	5.88e-07	3.29e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS1—hypertension	5.88e-07	3.29e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—MTHFR—hypertension	5.88e-07	3.29e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ADCY5—hypertension	5.83e-07	3.26e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GPX1—hypertension	5.81e-07	3.25e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3R1—hypertension	5.78e-07	3.24e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—NOS3—hypertension	5.78e-07	3.24e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARA—hypertension	5.76e-07	3.23e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP1A1—hypertension	5.75e-07	3.22e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PRKCA—hypertension	5.75e-07	3.22e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CTGF—hypertension	5.66e-07	3.17e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CXCL8—hypertension	5.65e-07	3.16e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CD36—hypertension	5.65e-07	3.16e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GOT2—hypertension	5.61e-07	3.14e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMGCR—hypertension	5.61e-07	3.14e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AGT—hypertension	5.58e-07	3.12e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—POMC—hypertension	5.55e-07	3.1e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—INS—hypertension	5.52e-07	3.09e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ADRA2A—hypertension	5.49e-07	3.07e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CALM1—hypertension	5.49e-07	3.07e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOE—hypertension	5.47e-07	3.06e-05	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—AKT1—hypertension	5.46e-07	3.06e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL2—hypertension	5.43e-07	3.04e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CAV1—hypertension	5.42e-07	3.03e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOA1—hypertension	5.41e-07	3.03e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6—hypertension	5.38e-07	3.01e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—MTHFR—hypertension	5.36e-07	3e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF1—hypertension	5.33e-07	2.99e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT2—hypertension	5.33e-07	2.98e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—EGFR—hypertension	5.31e-07	2.97e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS2—hypertension	5.29e-07	2.96e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARA—hypertension	5.26e-07	2.94e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—TH—hypertension	5.14e-07	2.88e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CALM2—hypertension	5.12e-07	2.87e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MMP9—hypertension	5.11e-07	2.86e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CDKN1A—hypertension	5.1e-07	2.85e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AGT—hypertension	5.09e-07	2.85e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PTEN—hypertension	5.08e-07	2.85e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SERPINE1—hypertension	5.07e-07	2.84e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CALM1—hypertension	5.01e-07	2.8e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GCG—hypertension	5e-07	2.8e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC2A4—hypertension	5e-07	2.8e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOE—hypertension	4.99e-07	2.79e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK8—hypertension	4.97e-07	2.78e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—AKT1—hypertension	4.96e-07	2.78e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CAV1—hypertension	4.94e-07	2.77e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOA1—hypertension	4.93e-07	2.76e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGF2—hypertension	4.9e-07	2.74e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RHOA—hypertension	4.89e-07	2.74e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EP300—hypertension	4.85e-07	2.71e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GOT1—hypertension	4.84e-07	2.71e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3R1—hypertension	4.84e-07	2.71e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOS3—hypertension	4.84e-07	2.71e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARG—hypertension	4.76e-07	2.67e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SRC—hypertension	4.72e-07	2.64e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—STK11—hypertension	4.7e-07	2.63e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP19A1—hypertension	4.7e-07	2.63e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—POMC—hypertension	4.7e-07	2.63e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—INS—hypertension	4.67e-07	2.62e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTEN—hypertension	4.61e-07	2.58e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—VEGFA—hypertension	4.59e-07	2.57e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RELA—hypertension	4.55e-07	2.55e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MTOR—hypertension	4.46e-07	2.5e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—EP300—hypertension	4.4e-07	2.46e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—COMT—hypertension	4.37e-07	2.45e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARG—hypertension	4.34e-07	2.43e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARGC1A—hypertension	4.31e-07	2.41e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GNB3—hypertension	4.31e-07	2.41e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMOX1—hypertension	4.29e-07	2.4e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCL8—hypertension	4.29e-07	2.4e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—POMC—hypertension	4.28e-07	2.4e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALB—hypertension	4.28e-07	2.4e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—INS—hypertension	4.26e-07	2.38e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CAT—hypertension	4.23e-07	2.37e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MYC—hypertension	4.23e-07	2.36e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TGFB1—hypertension	4.22e-07	2.36e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GNAS—hypertension	4.2e-07	2.35e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AKT1—hypertension	4.14e-07	2.32e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EGFR—hypertension	4.13e-07	2.31e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOB—hypertension	4.11e-07	2.3e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3R1—hypertension	4.1e-07	2.29e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NOS3—hypertension	4.1e-07	2.29e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6—hypertension	4.08e-07	2.28e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTM1—hypertension	4e-07	2.24e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LPL—hypertension	3.92e-07	2.2e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALB—hypertension	3.91e-07	2.19e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP9—hypertension	3.88e-07	2.17e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CDKN1A—hypertension	3.87e-07	2.16e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTEN—hypertension	3.86e-07	2.16e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ADCY5—hypertension	3.84e-07	2.15e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GPX1—hypertension	3.83e-07	2.14e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PRKCA—hypertension	3.79e-07	2.12e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP1A1—hypertension	3.79e-07	2.12e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK8—hypertension	3.77e-07	2.11e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKT1—hypertension	3.76e-07	2.11e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS2—hypertension	3.75e-07	2.1e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NOS3—hypertension	3.74e-07	2.09e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3R1—hypertension	3.74e-07	2.09e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CD36—hypertension	3.73e-07	2.09e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EP300—hypertension	3.68e-07	2.06e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SRC—hypertension	3.58e-07	2e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MTHFR—hypertension	3.53e-07	1.98e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—VEGFA—hypertension	3.48e-07	1.95e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TP53—hypertension	3.47e-07	1.94e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARA—hypertension	3.47e-07	1.94e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS2—hypertension	3.42e-07	1.91e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AGT—hypertension	3.36e-07	1.88e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CALM1—hypertension	3.3e-07	1.85e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOE—hypertension	3.29e-07	1.84e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTEN—hypertension	3.27e-07	1.83e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CAV1—hypertension	3.26e-07	1.82e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOA1—hypertension	3.25e-07	1.82e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MYC—hypertension	3.21e-07	1.79e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TGFB1—hypertension	3.2e-07	1.79e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6—hypertension	3.18e-07	1.78e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EGFR—hypertension	3.14e-07	1.76e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—EP300—hypertension	3.12e-07	1.74e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTEN—hypertension	2.98e-07	1.67e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT1—hypertension	2.93e-07	1.64e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARG—hypertension	2.87e-07	1.6e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—EP300—hypertension	2.84e-07	1.59e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—POMC—hypertension	2.83e-07	1.58e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—INS—hypertension	2.81e-07	1.57e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AKT1—hypertension	2.66e-07	1.49e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TP53—hypertension	2.63e-07	1.47e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALB—hypertension	2.58e-07	1.44e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3R1—hypertension	2.46e-07	1.38e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NOS3—hypertension	2.46e-07	1.38e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6—hypertension	2.41e-07	1.35e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS2—hypertension	2.25e-07	1.26e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT1—hypertension	2.22e-07	1.24e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTEN—hypertension	1.97e-07	1.1e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKT1—hypertension	1.88e-07	1.05e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—EP300—hypertension	1.87e-07	1.05e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKT1—hypertension	1.72e-07	9.61e-06	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKT1—hypertension	1.13e-07	6.34e-06	CbGpPWpGaD
